Non-invasive bladder cancer detection: Identification of a urinary volatile biomarker panel using GC-MS metabolomics and machine learning
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDP/04378/2020)
- Fundação para a Ciência e a Tecnologia (UIDB/04378/2020)
- Fundação para a Ciência e a Tecnologia (LA/P/0140/2020)
This publication has 57 references indexed in Scilit:
- The Financial Burden of Localized and Metastatic Bladder CancerEuropean Urology, 2024
- Sensitivity of Sniffer Dogs for a Diagnosis of Parkinson's Disease: A Diagnostic Accuracy StudyMovement Disorders, 2022
- An Introduction to Machine LearningClinical Pharmacology & Therapeutics, 2020
- The global burden of urinary bladder cancer: an updateWorld Journal of Urology, 2019
- Exploring the potential of needle trap microextraction combined with chromatographic and statistical data to discriminate different types of cancer based on urinary volatomic biosignatureAnalytica Chimica Acta, 2018
- How close are we to complete annotation of metabolomes?Current Opinion in Chemical Biology, 2017
- Headspace-programmed temperature vaporization-mass spectrometry for the rapid determination of possible volatile biomarkers of lung cancer in urineAnalytical and Bioanalytical Chemistry, 2016
- Effect size estimation: Methods and examplesInternational Journal of Nursing Studies, 2012
- Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder CancerEuropean Urology Supplements, 2009
- Proposed minimum reporting standards for chemical analysisMetabolomics, 2007